The New Guyana Pharmaceutical Corporation yesterday called on the Audit Office to carry out a ‘Value for Money” audit to determine if the Ministry of Health received value for purchases from the company.
In a statement, New GPC CEO Dr Ranjisinghi Ramroop said that the call is in the wake of queries of pricing disparities of drugs
